Otc Drug And Dietary Supplement Market Scope And Analysis

  • Report Code : TIPRE00012956
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

OTC Drug and Dietary Supplement Market Analysis Report 2031

Buy Now


OTC Drug and Dietary Supplement Market Report Scope

Report Attribute Details
Market size in 2023 US$ 367.01 Billion
Market Size by 2031 US$ 680.19 Billion
Global CAGR (2023 - 2031) 8.0%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Cough and Cold Products
  • Vitamins and Dietary Supplements
  • Analgesics
  • Gastrointestinal Products
  • Sleep Aids
  • Oral Care Products
  • Ophthalmic Products
  • Antacids
  • Feminine Care
By Type
  • Branded
  • Generic
By Form
  • Tablets
  • Capsules
  • Powders
  • Ointments
  • Liquid
By Distribution Channel
  • Hospital and Retail Pharmacies
  • Retail Stores
  • Online Channels
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • GlaxoSmithKline plc
  • Sanofi
  • Johnson and Johnson Services Inc
  • Abbott
  • AbbVie Inc
  • Bausch Health Companies Inc
  • Bayer AG
  • Procter Gamble
  • Novartis AG
  • Reckitt Benckiser Group Plc